Aprepitant for the management of nausea with inpatient IV dihydroergotamine

OBJECTIVE: To assess the efficacy and tolerability of oral aprepitant, a substance P/neurokinin A receptor antagonist, in controlling nausea associated with IV dihydroergotamine (DHE) administered for medically refractory migrainous headache in patients not responding to standard antiemetics or with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Denise E., Tso, Amy R., Goadsby, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067541/
https://www.ncbi.nlm.nih.gov/pubmed/27629088
http://dx.doi.org/10.1212/WNL.0000000000003206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067541/
https://www.ncbi.nlm.nih.gov/pubmed/27629088
http://dx.doi.org/10.1212/WNL.0000000000003206

Ejemplares similares